Rankings
▼
Calendar
TLSI Q3 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
Q3 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$7M
+41.5% YoY
Gross Profit
$6M
86.3% margin
Operating Income
-$9M
-118.9% margin
Net Income
-$2M
-32.6% margin
EPS (Diluted)
$-0.12
QoQ Revenue Growth
-0.2%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$27M
Total Liabilities
$48M
Stockholders' Equity
-$20M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$5M
+41.5%
Gross Profit
$6M
$5M
+37.8%
Operating Income
-$9M
-$19M
+53.1%
Net Income
-$2M
-$1M
-68.4%
← FY 2024
All Quarters
Q4 2024 →